Eisai Co., Ltd. (ESAIY)
7.31
-0.10
(-1.35%)
USD |
OTCM |
Oct 06, 16:00
Eisai Enterprise Value : 8.174B for Oct. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 8.174B |
| October 05, 2026 | 8.287B |
| October 02, 2026 | 8.332B |
| October 01, 2026 | 8.536B |
| September 30, 2026 | 8.830B |
| September 29, 2026 | 8.649B |
| September 28, 2026 | 9.112B |
| September 25, 2026 | 8.830B |
| September 24, 2026 | 8.897B |
| September 23, 2026 | 8.841B |
| September 22, 2026 | 8.954B |
| September 21, 2026 | 9.010B |
| September 18, 2026 | 8.784B |
| September 17, 2026 | 8.852B |
| September 16, 2026 | 8.717B |
| September 15, 2026 | 8.558B |
| September 14, 2026 | 8.570B |
| September 11, 2026 | 8.445B |
| September 10, 2026 | 8.355B |
| September 09, 2026 | 8.332B |
| September 08, 2026 | 8.361B |
| September 04, 2026 | 8.355B |
| September 03, 2026 | 8.581B |
| September 02, 2026 | 8.315B |
| September 01, 2026 | 8.208B |
| Date | Value |
|---|---|
| August 31, 2026 | 8.242B |
| August 28, 2026 | 8.344B |
| August 27, 2026 | 8.390B |
| August 26, 2026 | 8.399B |
| August 25, 2026 | 8.547B |
| August 24, 2026 | 8.479B |
| August 21, 2026 | 8.694B |
| August 20, 2026 | 8.615B |
| August 19, 2026 | 8.671B |
| August 18, 2026 | 8.355B |
| August 17, 2026 | 8.276B |
| August 14, 2026 | 8.476B |
| August 13, 2026 | 8.502B |
| August 12, 2026 | 8.721B |
| August 11, 2026 | 8.694B |
| August 10, 2026 | 8.660B |
| August 07, 2026 | 8.457B |
| August 06, 2026 | 8.163B |
| August 05, 2026 | 7.960B |
| August 04, 2026 | 8.197B |
| August 03, 2026 | 8.106B |
| July 31, 2026 | 8.344B |
| July 30, 2026 | 8.784B |
| July 29, 2026 | 8.671B |
| July 28, 2026 | 8.186B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 84.77B |
| Daiichi Sankyo Co., Ltd. | 30.92B |
| Chugai Pharmaceutical Co., Ltd. | 57.63B |
| Santen Pharmaceutical Co., Ltd. | 2.989B |
| Ono Pharmaceutical Co., Ltd. | 6.092B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 120.18M |
| Revenue (Quarterly) | 1.471B |
| Total Expenses (Quarterly) | 1.356B |
| EPS Diluted (Quarterly) | 0.1015 |
| Gross Profit Margin (Quarterly) | 78.20% |
| Profit Margin (Quarterly) | 8.17% |
| Earnings Yield | 3.32% |
| Operating Earnings Yield | 3.44% |
| Normalized Earnings Yield | 3.324 |